Is Aurora Cannabis (TSX:ACB) a Steal at Under $10?

In light of the challenges faced by its main rival, there could be an opportunity for Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) to win back some investors it may have lost.

| More on:

Investors haven’t been very bullish on marijuana stocks lately, and that could mean there might be some deals out there today. Aurora Cannabis (TSX:ACB)(NYSE:ACB) has seen only modest single-digit returns over the past year, as it has taken investors on a bit of a roller-coaster ride. However, with rival Canopy Growth (TSX:WEED)(NYSE:CGC) no longer having Bruce Linton to help steer the ship, it could be a great time to load up on Aurora’s stock. Let’s take a closer to look to see if it’s a good buy at around $10 or less.

Sales growth has been strong and not too far behind Canopy Growth

Over the past 12 months, Aurora’s sales have climbed to $168 million, and during that time the company has incurred losses of $211 million. However, in two of the past four quarters, Aurora has been able to stay in the black. In its most recent earnings report, the company benefited from $16 million in fair-value gains.

Canopy Growth, meanwhile, lost $685 million on sales of $226 million over the trailing 12 months. With about 34% more in sales than Aurora, the gap is not as big as the disparity in market cap would have you believe, as Canopy Growth often trades at more than double its valuation. Certainly, there are intangibles and other factors that drive up the value (like Canopy Growth being the industry leader and having some advantages, such as its strong brand and the personnel  it has involved with the company), but for the valuation to be more than double seems a bit high.

If we look at multiples to sales, Aurora trades at around 60 times the revenue it generated over the past year, while Canopy Growth is over 75. Both multiples are very high, but they suggest that Aurora may not be overpriced at all, especially in comparison to its strongest competitor.

Opportunity for Aurora to take advantage

Initially, having a partner like Constellation Brands gave Canopy Growth a big advantage over its peers — a partner with a lot of capital and the experience to help navigate the beverage segment certainly seemed like a big positive for the cannabis company. However, in light of recent events, it might be that Aurora is better off without a partner that might put pressure on its operations. Instead, Aurora has the potential to be more aggressive and take advantage of opportunities that Canopy Growth might now be more timid of, given its focus on improving profitability.

If Aurora takes a page out of Canopy Growth’s old playbook, it could be what the stock needs to get going to help show that the company is serious about being the top pot stock in the industry. If it does, it would certainly be a good deal at its current price.

Bottom line

There’s an opportunity for Aurora now to show to investors why it can be a better buy than Canopy Growth, and that’s going to be crucial in getting the markets excited about the stock. There’s definitely reason to believe that Aurora can rise in value from where it is today, but it’s going to need at least one big move to get the stock going again.  If you can buy the stock for under $10, it could prove to be a great buy.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »